Antioxidative potential of a combined therapy of anti TNF&alpha; and Zn acetate in experimental colitis

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 36

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

363

HTML

3173

Figures (1-1)

168

Tables (1-1)

204

Sum=3908

Sep 28, 2011 (publication date) through Jul 16, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Sep 28, 2011; 17(36): 4099-4103
Published online Sep 28, 2011. doi: 10.3748/wjg.v17.i36.4099

Full Size Figure Download Figure

Figure 1 8-hydroxydeoxyguanosine. ^aP < 0.05 vs controls; ^bP < 0.02 vs colitis; ^cP < 0.04 vs colitis. TNF: Tumour necrosis factor.

Citation: Barollo M, Medici V, D’Incà R, Banerjee A, Ingravallo G, Scarpa M, Patak S, Ruffolo C, Cardin R, Sturniolo GC. Antioxidative potential of a combined therapy of anti TNFα and Zn acetate in experimental colitis. World J Gastroenterol 2011; 17(36): 4099-4103
URL: https://www.wjgnet.com/1007-9327/full/v17/i36/4099.htm
DOI: https://dx.doi.org/10.3748/wjg.v17.i36.4099